NL-OMON43323CompletedPhase 4
Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: a pilot study - M&M trial
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Enrollment
- 40
Study Overview
Brief Summary
Trial is onging in other countries
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 18 to 64 (—)
Inclusion Criteria
- •* Early pregnancy failure, 6-14 weeks postmenstrual with a
- •o Crown-rump length * 6mm and no cardiac activity OR
- •o Gestational sac without embryonic pole, confirmed by a second ultrasound at least one week later
- •* At least one week after diagnosis OR a discrepancy of at least one week between crown-rump length and calendar gestational age
- •* Intra-uterine pregnancy
- •* Women aged above 18 years
- •* Hemodynamic stable patient
- •* No signs of infection
- •* No signs of incomplete abortion
- •* No contraindications for mifepristone or misoprostol
- •* No high risk of thrombosis
Exclusion Criteria
- •Patient does not meet inclusion criteria, discovered after randomization
- •Inability to give informed consent
Investigators
Similar Trials
Completed
Phase 4
Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: a randomized double blind placebo-controlled comparison (Triple M trial)early pregnancy failuremiscarriage10000211NL-OMON48955Radboud Universitair Medisch Centrum352
Completed
Not Applicable
Morphine intravenous vs. paracetamol intravenous after cardiac surgery in neonates and infants.post-operative pain100103941000751010007593NL-OMON47394Intensive Care Kinderen175
Completed
Not Applicable
The PaPa Trial: Paracetamol as an adjunct to intrapartum Remifentanil/PCA. An RCT of multimodal pain management during labor.NL-OMON49620Reinier de Graaf Groep79
Completed
Not Applicable
Mifepristone Versus Laminaria for Cervical Ripening in Midtrimester InductionAbortion, InducedNCT00383032Dartmouth-Hitchcock Medical Center72
Recruiting
Phase 3
Medicines for abortion between 10-20 weeksCTRI/2016/06/006980Concept foundation670